☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AstraZeneca's Farxiga and Xigduo XR Receives FDA's Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment
February 28, 2019
Janssen's Tremfya (guselkumab) Receives FDA's Approval for Moderate-to-Severe Plaque Psoriasis in Adults
February 28, 2019
Novartis Signs a Research Agreement with Target PharmaSolutions for Conducting TARGET-DERM Study
February 28, 2019
Novartis and Blackstone Life Sciences Collaborate to Launch Anthos Therapeutics for Cardiovascular Disorders
February 28, 2019
AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for Neurological Disorders
February 28, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions